A heterodimer of α and β hemoglobin chains functions as an innate anticancer agent
International Journal of Cancer · 2024
DOI: 10.1002/ijc.34702 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Maharrish Chelladurai und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Melanoma, Brain Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.
Abstract (Originalsprache)
Metastatic (as well as tumor) microenvironments contain both cancer‐promoting and cancer‐restraining factors. The balance between these opposing forces determines the fate of cancer cells that disseminate to secondary organ sites. In search for microenvironmental drivers or inhibitors of metastasis, we identified, in a previous study, the beta subunit of hemoglobin (HBB) as a lung‐derived antimetastatic factor. In the present study, exploring mechanisms regulating melanoma brain metastasis, we discovered that brain‐derived factors restrain proliferation and induce apoptosis and necrosis of brain‐metastasizing melanoma cells. Employing various purification procedures, we identified a heterodimer composed of hemoglobin alpha and beta chains that perform these antimetastatic functions. Neither the alpha nor the beta subunit alone was inhibitory. An alpha/beta chain dimer chemically purified from human hemoglobin inhibited the cell viability of primary melanomas, melanoma brain metastasis (MBM), and breast cancer cell lines. The dimer‐induced DNA damage, cell cycle arrest at the SubG1 phase, apoptosis, and significant necrosis in four MBM cell lines. Proteomic analysis of dimer‐treated MBM cells revealed that the dimer downregulates the expression of BRD4, GAB2, and IRS2 proteins, playing crucial roles in cancer cell sustainability and progression. Thus, we hypothesize that the hemoglobin dimer functions as a resistance factor against brain‐metastasizing cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel.
- Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Bioinformatics Unit, The George S. Wise Faculty of Life Science, Tel Aviv University, Tel-Aviv, Israel.
- Department of Translational Molecular Medicine and Sequencing Center, Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, California, USA.
ORCID-Profile: Dave S Hoon, Isaac P Witz
Förderung
- Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Zitieren
APA
Chelladurai, M., Xu, D., Izraely, S., Ben-Menachem, S., Bengaiev, R., Sagi-Assif, O., Yuan, W., Pasmanik Chor, M., Hoon, D. S., Lu, W., & Witz, I. P. (2024). A heterodimer of α and β hemoglobin chains functions as an innate anticancer agent. International Journal of Cancer. https://doi.org/10.1002/ijc.34702
Vancouver
Chelladurai M, Xu D, Izraely S, Ben-Menachem S, Bengaiev R, Sagi-Assif O, et al. A heterodimer of α and β hemoglobin chains functions as an innate anticancer agent. International Journal of Cancer. 2024. doi:10.1002/ijc.34702
BibTeX
@article{Chelladurai2024,
author = {Chelladurai, Maharrish and Xu, Dan and Izraely, Sivan and Ben-Menachem, Shlomit and Bengaiev, Roman and Sagi-Assif, Orit and Yuan, Weirong and Pasmanik Chor, Metsada and Hoon, Dave S and Lu, Wuyuan and Witz, Isaac P},
title = {A heterodimer of α and β hemoglobin chains functions as an innate anticancer agent},
journal = {International Journal of Cancer},
year = {2024},
doi = {10.1002/ijc.34702}
}
EUVIMED